Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.

By Marije van der Velde, K. Matsushita, Josef Coresh, B. Astor, M. Woodward, Andrew S. Levey, P. D. de Jong, R. Gansevoort, M. El-Nahas, Kai-Uwe Eckardt and 32 more. Kidney International, 2011

1,030 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association (2023, background): “22,23 Consequently, the most common causes of death for people with diabetes and CKD are HF and atherosclerotic CVD (ASCVD), 24–26 and only ≈ 10% of patients with CKD even survive to reach kidney failure.”
Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality (2014, neutral): “9) 10 (9, 11) 14 (13, 15) 19 (18, 20) 54 (53, 55)”
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. (2014, background): “Analyses performed for the purpose of this conference demonstrated that GFR and albuminuria are independent and complementary predictors of important clinical outcomes, including CKD progression, end-stage renal disease (ESRD), acute kidney injury (AKI), cardiovascular mortality, and all-cause morta”